Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein–Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant

References

• Leen AM, Tripic T, Rooney CM. Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation. Expert Opin Biol Ther. 2010;10: 337–51.
   PubMed Web of Science ®Google Scholar
• Myers GD, Bollard CM, Wu MF, . Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39:677–86.
   PubMed Web of Science ®Google Scholar
• Leen AM, Bollard CM, Myers GD, Rooney CM. Adenoviral infections in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12:243–51.
   Google Scholar
• Leen AM, Heslop HE. Cytotoxic T lymphocytes as immune-therapy in haematological practice. Br J Haematol. 2008; 143:169–79.
   PubMed Web of Science ®Google Scholar
• Leen AM, Myers GD, Sili U, . Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006;12:1160–6.
   PubMed Web of Science ®Google Scholar
• Peggs KS, Verfuerth S, Pizzey A, . Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet. 2003;362:1375–7.
   PubMed Web of Science ®Google Scholar
• Einsele H, Roosnek E, Rufer N, . Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002;99:3916–22.
   PubMed Web of Science ®Google Scholar
• Walter EA, Greenberg PD, Gilbert MJ, . Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333:1038–44.
   PubMed Web of Science ®Google Scholar
• Rooney CM, Smith CA, Ng CY, . Use of gene-modified virus-specific T lymphocytes to control Epstein–Barr-virus-related lymphoproliferation. Lancet. 1995;345:9–13.
   PubMed Web of Science ®Google Scholar
• Leen A, Ratnayake M, Foster A, . Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells. J Immunother. 2007;30:96–107.
   PubMed Web of Science ®Google Scholar
• Vera JF, Brenner LJ, Gerdemann U, . Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex). J Immunother. 2010;33:305–15.
   PubMed Web of Science ®Google Scholar
• Lapteva N, Vera JF. Optimization manufacture of virus- and tumor-specific T cells. Stem Cells Int. 2011;2011:434392.
   Google Scholar
• Leen AM, Sili U, Vanin EF, . Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross- reactive and subgroup-specific CD8 + T cells. Blood. 2004; 104:2432–40.
   PubMed Web of Science ®Google Scholar
• Gerdemann U, Christin AS, Vera JF, . Nucleofection of DCs to generate multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host. Mol Ther. 2009;17:1616–25.
   PubMed Web of Science ®Google Scholar
• Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein–Barr virus infection. J Exp Med. 2002;195:893–905.
   PubMed Web of Science ®Google Scholar
• Leen A, Meij P, Redchenko I, . Differential immunogenicity of Epstein–Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses. J Virol. 2001;75:8649–59.
   PubMed Web of Science ®Google Scholar
• Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein–Barr virus. Annu Rev Immunol. 2007;25:587–617.
   PubMed Web of Science ®Google Scholar
• Leen AM, Christin A, Khalil M, . Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J Virol. 2008;82:546–54.
   PubMed Web of Science ®Google Scholar
• Leen AM, Christin A, Myers GD, . Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein–Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood. 2009;114:4283–92.
   PubMed Web of Science ®Google Scholar
• Melenhorst JJ, Leen AM, Bollard CM, . Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood. 2010;116:4700–2.
   PubMed Web of Science ®Google Scholar